{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ01690",
      "entity_text" : "cathepsin",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-0721" ],
      "Organ" : [ "uberon:UBERON:0000062" ],
      "CellType" : [ "cl:CL:0000092" ]
    }
  },
  "verbose_text" : "The direct osteoclast inhibitory functions of BiP in vitro were manifest at two levels, inhibition of osteoclast precursors as well as mature osteoclasts characterized by inhibition of F-actin rings and/or expression of the osteoclast markers TRAP, VnR, and cathepsin K. Taken together, these results predict that BiP will have therapeutic value in human localized and systemic osteolytic disease because of its dual action on mature osteoclast function and differentiation in addition to its anti-inflammatory properties.",
  "reading_complete" : "2020-08-08T11:03:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:00:05Z",
  "trigger" : "expression",
  "evidence" : [ "expression of the osteoclast markers TRAP, VnR, and cathepsin" ],
  "pmc_id" : "6857990",
  "score" : 0
}